BenzingaThu, 18 Jun 2026 17:38:31 GMTRelmada's Cancer Drug Candidate Sparks Fresh Bullish CallRLMD-1.00%
Seeking AlphaWed, 13 May 2026 01:30:47 GMTRelmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call TranscriptRLMD-1.00%
Zacks Investment ResearchMon, 13 Apr 2026 14:55:42 GMTDoes Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?RLMD-1.00%